farmaco semaglutide ACC 2025: Oral Reduces Cardiovascular Events by 14% at 4 Years Semaglutide 3 Diabetes Drug Could Help Reduce

Insulin glargine and lixisenatide (Soliqua) injection [package insert]

The MHRA has highlighted that DKA can occur when concomitant insulin is rapidly reduced or discontinued when starting a GLP-1 receptor agonist

Studies have found that for chronic fissure, surgery is much more effective than any medical treatment

As we discuss the economic consequences, it is important to discuss the patient impact as obesity is a risk factor for cardiovascular sequelae and mortality

As patients dont feel like eating, theyre not prompted to hydrate regularly either, explains Dr Debra Marcos, who is both medical director at Weight Medics and a specialist in gastroenterology, clinical nutrition and GLP-1 therapy